Intraplaque hemorrhage assessed by high-resolution magnetic resonance imaging and C-reactive protein in carotid atherosclerosis

Journal of Vascular Surgery

Volumn 46, Issue 6, 2007, Pages 1130-1137

  Albuquerque, Luciano Cabral ^a   Narvaes, Luciane Barreneche ^a   Maciel, Aluísio Antunes ^a   Staub, Henrique ^a   Friedrich, Maurício ^a   Filho, João Rubião Hoefel ^b   Marques, Maurício Barreira ^b   Rohde, Luis Eduardo ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLEEDING; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HISTOLOGY; HUMAN; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STENOSIS; TRANSIENT ISCHEMIC ATTACK;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID STENOSIS; CEREBROVASCULAR DISORDERS; ENDARTERECTOMY, CAROTID; FEMALE; HEMORRHAGE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 37349115965     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.07.041     Document Type: Article

References (37)

1. Hankey G.J. Stroke: how large a public health problem, and how can the neurologist help?. Arch Neurol 56 (1999) 748-754
2. Goldstein L.B., Adams R., Becker K., Furberg C.D., Gorelick P.B., Hademenos G., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 32 (2001) 280-299
3. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee of the American Heart Association. Circulation 91 (1995) 566-579
4. Fuster V., Moreno P.M., Fayad Z.A., Corti R., and Badimon J.J. Atherothrombosis and high-risk plaque. J Am Coll Cardiol 46 (2005) 937-954
5. Mann J.M., and Davies M.J. Vulnerable plaque: relation of characteristics to degree of stenosis in human coronary arteries. Circulation 94 (1996) 928-931
6. Rohde L.E., and Lee R.T. Pathophysiology of atherosclerotic plaque development and rupture: an overview. Semin Vasc Med 3 (2003) 347-354
7. Modifi R., Crotty T.B., McCarthy P., Sheehan S.J., Mehigan D., and Keaveny T.V. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg 88 (2001) 945-950
8. Mullenix O.S., Andersen C.A., and Starnes B.W. Atherosclerosis as inflammation. Ann Vasc Surg 19 (2005) 130-138
9. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
10. Koenig W. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. Int J Cardiol 98 (2005) 199-206
11. Biasucci L.M. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110 (2004) e560-e567
12. Makita S., Nakamura M., and Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 36 (2005) 2138-2142
13. Schillinger M., Exner M., Mlekusch W., Sabeti S., Amighi J., Nikowitsch R., et al. Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). Circulation 111 (2005) 2203-2209
14. Rost N.S., Wolf P.A., Kase C.S., Kelly-Haes M., Silbershatz H., Massaro J.M., et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32 (2001) 2575-2579
15. Garcia B.A., Ruiz C., Chacon P., Sabin J.Á., and Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 38 (2003) 1018-1024
16. Nighoghossian N., Derex L., and Douek P. The vulnerable carotid artery plaque. Current imaging methods and new perspectives. Stroke 36 (2005) 2764-2772
17. Moody A.R., Murphy R.E., Morgan P.S., Martel A.L., Delay G.S., Allder S., et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107 (2003) 3047-3052
18. Murphy R.E., Moody A.R., Morgan P.S., Martel A.L., Delay G.S., Allder S., et al. Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 107 (2003) 3053-3058
19. Chu B., Kampschulte A., Ferguson M., Kerwin W.S., Yarnykh V.L., O'Brian K.D., et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution study. Stroke 35 (2004) 1079-1084
20. Kampschulte A., Ferguson M.S., Kerwin W.S., Nayak L., Polissar, Chu B., et al. Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 110 (2004) 3239-3244
21. Barnett H.J.M., Taylor D.W., Eliasziw M., Fox A.J., Ferguson G.G., Haynes R.B., et al., North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderated or severe stenosis. N Engl J Med 339 (1998) 1415-1425
22. MRC asymptomatic carotid surgery trial (ACST) collaborative group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet 363 (2004) 1491-1502
23. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy im symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
24. Nederkoorn P.J., van der Graaf Y., and Hunink M.G. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke 34 (2003) 1324-1332
25. Whicher J.T., Ritchie R.F., Johnson A.M., Baudner S., Bienvenu J., Blirup-Jensen S., et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 40 (1994) 934-938
26. Lovett J.K., Redgrave J.N.E., and Rothwell P.M. A critical appraisal of the performance, reporting, and interpretation of studies comparing carotid plaque imaging with histology. Stroke 36 (2005) 1091-1097
27. Lusby R.J., Ferrell L.D., Ehrenfeld W.K., Stoney R.J., and Wylie E.J. Carotid plaque hemorrhage. Its role in production of cerebral ischemia. Arch Surg 117 (1982) 1479-1488
28. Hatsukami T.S., Ross R., Polissar N.L., and Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102 (2000) 959-964
29. Cappendijk V.C., Cleutjens K.B., Kessels A.G., Heeneman S., Schurink G.W., Welten R.J., et al. Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: initial experience. Radiology 234 (2005) 487-492
30. Jander S., Sitzer M., Schumann R., Schroeter M., Siebler M., Steinmetz H., and Stoll G. Inflammation in high-grade carotid stenosis. A possible role for macrophages and T cells in plaque destabilization. Stroke 29 (1998) 1625-1630
31. Gonçalves I., Moses J., Dias N., Pedro L.M., Fernandes J.F., Nilsson J., et al. Changes related to age and cerebral vascular symptoms in the extracellular matrix of human carotid plaques. Stroke 34 (2003) 616-622
32. Wang T.J., Nam B., Wilson P.F., Wolf P.A., Levy D., Polak J.F., et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham heart study. Arterioscler Thromb Vasc Biol 22 (2002) 1662-1667
33. Wang T.J., Nam B., Wilson P.W.F., Wolf P.A., Levy D., Polak J.F., et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham heart study. Arterioscler Thromb Vasc Biol 22 (2002) 1662-1667
34. Cao J.J., Thach C., Manolio T.A., Psaty B.M., Kuller L.H., Chaves P.H., et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 108 (2003) e9002-e9003
35. Saam T., Cai J., Ma L., Cai Y.O., Fergusom M.S., Polissar N.L., Hatsukami T.S., et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 240 (2006) 464-472
36. Takaya N., Yuan C., Chu B., Saam T., Underhill H., Cai J., et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events. A prospective assessment with mri-initial results. Stroke 37 (2006) 818-823
37. Yuan C., Mitsumori L.M., Beach K.W., and Maravilla K.R. Carotid atherosclerotic plaque: noninvasive MR characterization of vulnerable lesions. Radiology 221 (2001) 285-299